Trinity Strategy: Enabling Perovskite as Hydrophilic and Efficient Fluorescent Nanozyme for Constructing Biomarker Reporting Platform

Water instability and sensing homogeneity are the Achilles’ heel of CsPbX 3 NPs in biological fluids application. This work reports the preparation of Mn 2+:CsPbCl 3 @SiO 2 yolk–shell nanoparticles (YSNPs) in aqueous solutions created through the integration of ligand, surface, and crystal engineering strategies. The S N 2 reaction between 4-chlorobutyric acid (CBA) and oleylamine (OAm) yields a zwitterionic ligand that facilitates the dispersion of YSNPs in water, while the robust SiO 2 shell enhances their overall stability. Besides, Mn 2+ doping in YSNPs not only introduces a second emission center but also enables potential postsynthetic designability, leading to the switching from YSNPs to MnO 2 @YSNPs with excellent oxidase (OXD)-like activity. Theoretical calculations reveal that electron transfer from CsPbCl 3 to in situ MnO 2 and the adsorption–desorption process of 3,3′,5,5′-tetramethylbenzidine (TMB) synergistically amplify the OXD-like activity. In the presence of ascorbic acid (AA), Mn 4+ in MnO 2 @YSNPs (fluorescent nanozyme) is reduced to Mn 2+ and dissociated, thereby inhibiting the OXD-like activity and triggering fluorescence “turn-on/off”, i.e., dual-mode recognition. Finally, a biomarker reporting platform based on MnO 2 @YSNPs fluorescent nanozyme is constructed with AA as the reporter molecule, and the accurate detection of human serum alkaline phosphatase (ALP) is realized, demonstrating the vast potential of perovskites in biosensing.